Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2
Martin Friedlander, MD, PhD
Advertisement
Articles by Martin Friedlander, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
2
European Dry Eye Society Congress 2026: real-world evidence on Artelac Complete in dry eye disease
3
AI-predicted retinal function shows promise in geographic atrophy
4
Study examines accommodation after iris-fixated phakic IOL implantation
5